<DOC>
	<DOC>NCT00148551</DOC>
	<brief_summary>A 24 - month Study looking at the the changes in visual acuity of patients receiving PDT therapy in conjunction with intravitreal triamcinolone.</brief_summary>
	<brief_title>Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.</brief_title>
	<detailed_description>This study will evaluate the effect of Triamcinolone Acetonide in conjunction with photodynamic therapy for the treatment of sub-foveal choroidal neovascular membranes secondary to age-related macular degeneration.</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Individuals with predominantly classic, subfoveal CNV secondary to AMD. No previous PDT Treatment in study eye. CNV from conditions, other than AMD. Other disease that could be responsible for decreased vision.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>AMD</keyword>
	<keyword>Triamcinolone</keyword>
	<keyword>Macular Degeneration</keyword>
</DOC>